GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma

por Negroni, Caterina, Hilton, David A., Ercolano, Emanuela, Adams, Claire L., Kurian, Kathreena M., Baiz, Daniele, Hanemann, C.Oliver
Publicado 2020

Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells

por Ferluga, Sara, Baiz, Daniele, Hilton, David A, Adams, Claire L, Ercolano, Emanuela, Dunn, Jemma, Bassiri, Kayleigh, Kurian, Kathreena M, Hanemann, Clemens O
Publicado 2020

BAD Dephosphorylation and Decreased Expression of MCL-1 Induce Rapid Apoptosis in Prostate Cancer Cells

por Yancey, Dana, Nelson, Kyle C., Baiz, Daniele, Hassan, Sazzad, Flores, Anabel, Pullikuth, Ashok, Karpova, Yelena, Axanova, Linara, Moore, Victoria, Sui, Guangchao, Kulik, George
Publicado 2013

The Potential of MLN3651 in Combination with Selumetinib as a Treatment for Merlin-Deficient Meningioma

por Lyons Rimmer, Jade, Ercolano, Emanuela, Baiz, Daniele, Makhija, Mahindra, Berger, Allison, Sells, Todd, Stroud, Steve, Hilton, David, Adams, Claire L., Hanemann, C Oliver
Publicado 2020

Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas

por Sofela, Agbolahan A., Hilton, David A., Ammoun, Sylwia, Baiz, Daniele, Adams, Claire L., Ercolano, Emanuela, Jenkinson, Michael D., Kurian, Kathreena M., Teo, Mario, Whitfield, Peter C., Sahm, Felix, Hanemann, C. Oliver
Publicado 2021